lgh447
Showing 1 - 4 of 4
AML and High Risk MDS Trial in Worldwide (LGH447, LGH447 + midostaurin)
Completed
- AML and High Risk MDS
- LGH447
- LGH447 + midostaurin
-
Ann Arbor, Michigan
- +8 more
Dec 16, 2020
Multiple Myeloma Trial in Japan (LGH447)
Completed
- Multiple Myeloma
- LGH447
-
Nagoya-city, Aichi, Japan
- +3 more
Dec 16, 2020
Relapsed and Refractory Multiple Myeloma Trial in Worldwide (LGH447, BYL719)
Completed
- Relapsed and Refractory Multiple Myeloma
- LGH447
- BYL719
-
Houston, Texas
- +7 more
Dec 16, 2020